Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.620
+0.083 (15.44%)
Nov 4, 2024, 4:00 PM EST - Market closed
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$3,226,007
Market Cap
96.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus BioSciences | 306 |
| PetMed Express | 287 |
| Armata Pharmaceuticals | 66 |
| PMV Pharmaceuticals | 63 |
| Ikena Oncology | 43 |
| Vistagen Therapeutics | 40 |
| Eupraxia Pharmaceuticals | 29 |
| MediciNova | 13 |
RENB News
- 10 hours ago - Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewsWire
- 18 days ago - RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing - GlobeNewsWire
- 19 days ago - Renovaro Announces Strategic Restructuring and Leadership Transition - GlobeNewsWire
- 7 weeks ago - RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress - GlobeNewsWire
- 7 weeks ago - RenovaroCube Announces Strategic Offering of Up to 20% Ownership - GlobeNewsWire
- 5 months ago - Renovaro, Inc. Announces $10 million in Equity Committed - GlobeNewsWire
- 5 months ago - Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy - GlobeNewsWire
- 5 months ago - Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB) - Benzinga